The Medusind, Inc. Data Breach: Reported Filing Facts
Medusind, Inc. is a specialized healthcare revenue cycle management and medical billing company that processes sensitive patient and provider information. Given the nature of their business, the company typically collects and stores highly personal data, including patient demographics, clinical details, and insurance billing records. In 2025, Medusind, Inc. officially reported a data security incident to the Delaware Attorney General, confirming that unauthorized access to their systems occurred. If you have received a formal data breach notification letter from the company, it indicates that your personal or protected health information may have been compromised during this event. This notification is intended to inform you of the incident and provide guidance on the steps you should take to monitor and protect your identity.
- State
- Delaware
- Breach date
- December 29, 2023
- Reported
- January 7, 2025
What to do if you were affected
These general steps can help limit the risk of identity theft and fraud after any data breach.
Stay alert to targeted scams
Be cautious of calls, texts, or emails that reference this breach. Legitimate organizations won't ask you to confirm sensitive details through an unsolicited message.
Keep your notification letter
Save the notice you received. It documents that your information was involved and is often needed to enroll in any credit monitoring offered or to join a related legal claim.
Related data breach cases
- Anne Arundel Dermatology
- Johnson Controls
- Kelly & Associates Addendum
- SouthEast Series of Lockton Companies, LLC. (“Lockton”) Addendum
- Lemonade Inc. Addendum
- McLean Mortgage Corporation
- Kelly and Associates Ins. Group Supplemental Notice
- LexisNexis Risk Solutions
- Water Pro, Inc. d/b/a Culligan Water
- EB Archbald and Associates, Inc.
- Change Healthcare (DE Update from 2024 Notice)
- The Hertz Corporation, including the Hertz Dollar and Thrifty Brands
- Kelly and Associates Ins. Group
- Monro, Inc.